Form 4: Bio-Rad Executive Acquires Shares on Vesting

Bio-Rad Laboratories' EVP and CFO, Roop Kalyan Lakkaraju, acquired 1,078 shares of Class A common stock upon the vesting of restricted stock units.

Summary

• Roop Kalyan Lakkaraju, EVP and Chief Financial Officer of Bio-Rad Laboratories, Inc., reported a transaction on April 24, 2026.
• This transaction involved the acquisition of 1,078 shares of Bio-Rad A Common Stock.
• These shares were acquired as a result of the vesting of restricted stock units.
• Additionally, the filing notes the acquisition of 62.2360 shares under the Bio-Rad Employee Stock Purchase Plan on March 31, 2026.
• The reporting person also disposed of 420 shares of Bio-Rad A Common Stock at a price of $287.84 per share on April 24, 2026.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it primarily reports on routine insider transactions related to executive compensation and equity management, with both acquisitions and disposals noted.

Positives

• The acquisition of shares through vesting indicates continued equity participation and potential long-term alignment with the company's performance for a key executive.
• The acquisition of shares under the Employee Stock Purchase Plan suggests ongoing employee engagement and investment in the company.

Negatives

• The disposal of 420 shares of Bio-Rad A Common Stock at $287.84 per share represents a reduction in the executive's direct holdings.

Future Outlook

No specific forward-looking statements or guidance were provided in this Form 4 filing.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions and provide transparency into executive compensation and equity holdings. This filing details routine events like stock vesting and potential sales by a senior executive.

Stakeholder Impact

• Shareholders: Increased transparency into executive equity holdings and potential changes in insider ownership levels.
• Employees: The Employee Stock Purchase Plan acquisition may reflect ongoing employee participation and investment in the company.
• Management: The vesting of restricted stock units reinforces the alignment of executive compensation with company performance.

Key Dates

Keywords

Form 4, SEC Filing, Insider Transaction, Bio-Rad Laboratories, BIO, BIO.B, Stock Vesting, Restricted Stock Units, Employee Stock Purchase Plan, Executive Compensation, Beneficial Ownership